EventsThe 6th International Electronic Conference on Atmospheric Sciences
Published
with-doi10.3390/ecas2023-16349 (registering DOI)
This submission belongs to the session S2. Air Quality and Human Health of the event The 6th International Electronic Conference on Atmospheric Sciences
Published date
27 Nov, 2023
Academic Editor
author-avatarDaniele Contini
Citation
Wells Utembe, Arox Wadson Kamng'ona, The knowns and unknowns of chemically-induced lung microbiota dysbiosis and disease, in Proceedings of The 6th International Electronic Conference on Atmospheric Sciences, 15 October–30 October 2023, MDPI: Basel, Switzerland, doi: 10.3390/ecas2023-16349
Share
Email
Facebook
Twitter
LinkedIn

The knowns and unknowns of chemically-induced lung microbiota dysbiosis and disease

1. Toxicology and Biochemistry Department, National Institute for Occupational Health (NIOH), National Health Laboratory Services (NHLS), Johannesburg, South Africa, South Africa
2. Department of Biomedical Sciences, Kamuzu University of Health Sciences, Blantyre, Malawi, Malawi
Abstract

The human microbiota comprises of the ecological community of commensal and pathogenic microorganisms that colonise the human body along with the complex interactions of these microbes with the host. The advent of culture-independent methodologies has revealed the complex and dynamic community of microbes harboured by the human body. Whilst numerous studies conducted on the gut have shown the link between microbiota and a number of human diseases and conditions, very little is documented about the respiratory tract due to the difficulty in collecting GM samples. In addition, not much is known about the effect of chemical exposure on lung microbiota dysbiosis and subsequent linkage to respiratory tract infections. This study critically analyses the known and unknown facts about chemically induced lung microbiota (LM) dysbiosis and disease. The lungs are a non-sterile environment harbouring a microbiota configuration that is distinct from that which inhabits the gastrointestinal tract and other parts of the human body. It is now being recognized that LM can directly impact immunity in manner that can result in disease. Significant differences in community composition have been shown between the LM of diseased lungs with those of healthy subjects. Studies have linked LM dysbiosis with human diseases such Idiopathic Pulmonary Fibrosis, lung inflammation, chronic obstructive pulmonary disease (COPD), asthma, and lung cancer. However, it is not known whether LM dysbiosis initiates/promotes disease pathogenesis or is merely a biomarker of disease. Furthermore, what metabolites can be linked to individual disease conditions? Do metabolites play significant roles in LM dysbiosis and disease as they do in GM dysbiosis? Most importantly, is LM amenable to therapeutic manipulation in a manner that can change disease progression? Finally, in order to fully understand the role of LM on human diseases, there is need to investigate other lung microorganisms other than bacteria and viruses.

Keywords
Lung microbiota
disease
air pollutants
dysbiosis
Manuscript
Association between ambient air pollution by particulate matter (PM2.5) and vehicular traffic in the downtown of the port city of Tampico, Mexico
Urban environment and human health: the motivations for urban regeneration to adapt.